Sun Pharmaceutical Industries Ltd.
-31.35 (-1.84%) Sun Pharmaceutical Industries reports 17% rise in Q3 consolidated net profit
Date: 31-01-2024Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported 48.20% rise in net profit at Rs 721.31 crore for the third quarter ended December 31, 2023 as compared to Rs 486.73 crore for the same quarter in the previous year. Total income of the company increased by 9.27% at Rs 5150.55 crore for Q3FY24 as compared Rs 4713.78 crore for corresponding quarter of the previous year.
On consolidated basis, the company reported 17.42% rise in its net profit at Rs 2560.54 crore for Q3FY24 as compared to Rs 2180.75 crore for the same quarter in the previous year. Total income of the company increased by 10.65% at Rs 12630.90 crore for Q3FY24 as compared Rs 11414.85 crore for corresponding quarter of the previous year.